Literature DB >> 9830439

X-ray induced changes in immunostaining of proliferating cell nuclear antigen (PCNA) in V79 hamster fibroblasts.

F Lohr1, H Hof, K J Weber, D Latz, F Wenz.   

Abstract

BACKGROUND: Proliferating cell nuclear antigen (PCNA) ist a 36 kD protein that is involved in DNA-replication and -repair. For V79 hamster cells, a mutated p53 and a so-called "adaptive response", an improved radiation tolerance after pre-irradiation with low X-ray doses hours before definitive irradiation with higher doses have been reported. To better understand the role of PCNA after photon irradiation in vivo, using flow cytometry, we studied the immunochemical PCNA-staining in V79 cells after irradiation with 6-MeV photons with and without serum depletion and with and without low-dose pre-irradiation under different growth conditions.
MATERIAL AND METHODS: Using V79 hamster cells, BrdUrd incorporation, total and DNA-bound PCNA were measured for exponential cells and for confluent cells at different times (up to 14 days) after reaching confluence. Cells were either grown with medium containing 10% fetal calf serum (FCS) or 0.5% FCS. Six days after reaching confluence, cells were irradiated with 1 Gy (and 8 Gy for non-serum-depleted cells) (6-MV photons, 2 Gy/min). Then, immunochemical PCNA-staining was measured by flow cytometry at 0, 30, 60 and 120 min after irradiation. For studying the adaptive response, exponentially growing cells and cells that were 6 days in confluence were pretreated with 0.01 Gy, reincubated for 5 h and then definitively treated with 1 Gy and harvested and processed as described above.
RESULTS: Four days after reaching confluence, DNA-bound PCNA and BrdUrd content were reduced to a minimum of < 15% positive cells while total PCNA remained essentially unchanged. After irradiation with 1 Gy 6 days after reaching confluence, cells grown with 10% FCS showed a moderate but distinct transient increase in DNA-bound PCNA at 30 min after irradiation. After irradiation with 8 Gy, there was no clear increase at 30 min but a more distinct decrease at 60 min, implying that the increase might occur earlier in the time course at higher doses. Total cellular PCNA and BrdUrd uptake were constant during the first 2 hours after irradiation. In cells that were kept with serum depleted medium for 6 days after reaching confluence, total PCNA was reduced and no changes in either DNA-bound PCNA or BrdUrd-uptake were observed after irradiation. When cells were primed with a dose of 0.01 Gy 5 h before subsequent treatment with 1 Gy, neither for exponentially growing cells nor for those in confluence a significant difference in the detected amount of PCNA (total and DNA-bound) or BrdUrd was observed when compared to cells treated without a priming dose.
CONCLUSIONS: The moderate X-ray induced DNA association of PCNA is indicative for ongoing DNA repair but appears to require serum stimuli. However, this p53-independent pathway involving PCNA does not seem to be the most relevant for survival in these rodent cells that tolerate much residual damage. Furthermore, no adaptive response for DNA-association of PCNA could be detected in V79 cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9830439     DOI: 10.1007/bf03038295

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  26 in total

1.  No adaptive response of Chinese hamster ovary cells to low doses of ionizing radiation.

Authors:  H C Andersson; S Na Chiangmai
Journal:  Hereditas       Date:  1992       Impact factor: 3.271

2.  A novel DNA repair response is induced in human cells exposed to ionizing radiation at the G1/S-phase border.

Authors:  S A Leadon; A B Dunn; C E Ross
Journal:  Radiat Res       Date:  1996-08       Impact factor: 2.841

3.  Induction of the adaptive response by X-rays is dependent on radiation intensity.

Authors:  J D Shadley; J K Wiencke
Journal:  Int J Radiat Biol       Date:  1989-07       Impact factor: 2.694

4.  Repair Defect in p21 WAF1/CIP1 -/- human cancer cells.

Authors:  E R McDonald; G S Wu; T Waldman; W S El-Deiry
Journal:  Cancer Res       Date:  1996-05-15       Impact factor: 12.701

5.  Role for c-Abl tyrosine kinase in growth arrest response to DNA damage.

Authors:  Z M Yuan; Y Huang; Y Whang; C Sawyers; R Weichselbaum; S Kharbanda; D Kufe
Journal:  Nature       Date:  1996-07-18       Impact factor: 49.962

6.  The response of proliferating cell nuclear antigen to ionizing radiation in human lymphoblastoid cell lines is dependent on p53.

Authors:  F Wenz; E I Azzam; J B Little
Journal:  Radiat Res       Date:  1998-01       Impact factor: 2.841

7.  Flow cytometric measurement of proliferating cell nuclear antigen (PCNA) in solid tumors.

Authors:  F Wenz; F Lohr; M Flentje
Journal:  Strahlenther Onkol       Date:  1994-04       Impact factor: 3.621

8.  DNA polymerase delta holoenzyme: action on single-stranded DNA and on double-stranded DNA in the presence of replicative DNA helicases.

Authors:  V N Podust; L M Podust; F Müller; U Hübscher
Journal:  Biochemistry       Date:  1995-04-18       Impact factor: 3.162

9.  Proliferating cell nuclear antigen-dependent abasic site repair in Xenopus laevis oocytes: an alternative pathway of base excision DNA repair.

Authors:  Y Matsumoto; K Kim; D F Bogenhagen
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

10.  Characterization of X-ray-induced immunostaining of proliferating cell nuclear antigen in human diploid fibroblasts.

Authors:  M Miura; T Sasaki; Y Takasaki
Journal:  Radiat Res       Date:  1996-01       Impact factor: 2.841

View more
  2 in total

1.  Radiochemotherapy with paclitaxel: synchronization effects and the role of p53.

Authors:  F Wenz; S Greiner; F Germa; K Mayer; D Latz; K J Weber
Journal:  Strahlenther Onkol       Date:  1999-10       Impact factor: 3.621

Review 2.  Chemotherapy and Physical Therapeutics Modulate Antigens on Cancer Cells.

Authors:  Wojciech Szlasa; Natalia Janicka; Natalia Sauer; Olga Michel; Bernadetta Nowak; Jolanta Saczko; Julita Kulbacka
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.